 MARIETTA, Ga., April 20, 2022 GLOBE NEWSWIRE -- MiMedx Group, Inc. Nasdaq: MDXG MIMEDX or the Company, a transformational placental biologics company, today announced that it will report operating and financial results for the first quarter ended March 31, 2022 after the market close on Tuesday, May 3, 2022. The MIMEDX senior management team will host a webcast and conference call to review its results on Wednesday, May 4, 2022, beginning at 8:30 a.m. Eastern Time. 